Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Purinergic receptor X7 is a key modulator of metabolic oxidative stress-mediated autophagy and inflammation in experimental nonalcoholic steatohepatitis.

Das S, Seth RK, Kumar A, Kadiiska MB, Michelotti G, Diehl AM, Chatterjee S.

Am J Physiol Gastrointest Liver Physiol. 2013 Dec;305(12):G950-63. doi: 10.1152/ajpgi.00235.2013. Epub 2013 Oct 24.

2.

CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis.

Seth RK, Das S, Kumar A, Chanda A, Kadiiska MB, Michelotti G, Manautou J, Diehl AM, Chatterjee S.

Toxicol Appl Pharmacol. 2014 Jan 1;274(1):42-54. doi: 10.1016/j.taap.2013.10.029. Epub 2013 Nov 7.

3.

M1 polarization bias and subsequent nonalcoholic steatohepatitis progression is attenuated by nitric oxide donor DETA NONOate via inhibition of CYP2E1-induced oxidative stress in obese mice.

Seth RK, Das S, Pourhoseini S, Dattaroy D, Igwe S, Ray JB, Fan D, Michelotti GA, Diehl AM, Chatterjee S.

J Pharmacol Exp Ther. 2015 Jan;352(1):77-89. doi: 10.1124/jpet.114.218131. Epub 2014 Oct 27.

4.

Environmental toxin-linked nonalcoholic steatohepatitis and hepatic metabolic reprogramming in obese mice.

Seth RK, Kumar A, Das S, Kadiiska MB, Michelotti G, Diehl AM, Chatterjee S.

Toxicol Sci. 2013 Aug;134(2):291-303. doi: 10.1093/toxsci/kft104. Epub 2013 May 2.

5.

Regulation of oxidative stress and inflammation by hepatic adiponectin receptor 2 in an animal model of nonalcoholic steatohepatitis.

Matsunami T, Sato Y, Ariga S, Sato T, Kashimura H, Hasegawa Y, Yukawa M.

Int J Clin Exp Pathol. 2010 May 22;3(5):472-81.

6.

P2X7 receptor as a key player in oxidative stress-driven cell fate in nonalcoholic steatohepatitis.

Chatterjee S, Das S.

Oxid Med Cell Longev. 2015;2015:172493. doi: 10.1155/2015/172493. Epub 2015 Mar 1. Review.

7.

Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice.

Haque JA, McMahan RS, Campbell JS, Shimizu-Albergine M, Wilson AM, Botta D, Bammler TK, Beyer RP, Montine TJ, Yeh MM, Kavanagh TJ, Fausto N.

Lab Invest. 2010 Dec;90(12):1704-17. doi: 10.1038/labinvest.2010.112. Epub 2010 Jun 14.

8.

Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis.

Abdelmegeed MA, Banerjee A, Yoo SH, Jang S, Gonzalez FJ, Song BJ.

J Hepatol. 2012 Oct;57(4):860-6. doi: 10.1016/j.jhep.2012.05.019. Epub 2012 Jun 2.

9.

Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease.

Machado MV, Michelotti GA, Xie G, Almeida Pereira T, Boursier J, Bohnic B, Guy CD, Diehl AM.

PLoS One. 2015 May 27;10(5):e0127991. doi: 10.1371/journal.pone.0127991. eCollection 2015. Erratum in: PLoS One. 2015;10(6):e0132315. de Almeida, Thiago Pereira [corrected to Almeida Pereira, Thiago].

10.

Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.

Min AK, Kim MK, Kim HS, Seo HY, Lee KU, Kim JG, Park KG, Lee IK.

Life Sci. 2012 Jan 30;90(5-6):200-5. doi: 10.1016/j.lfs.2011.11.012. Epub 2011 Dec 1.

PMID:
22154902
11.

CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.

Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR.

J Clin Invest. 2000 Apr;105(8):1067-75.

12.

CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy.

Zhang X, Han J, Man K, Li X, Du J, Chu ES, Go MY, Sung JJ, Yu J.

J Hepatol. 2016 Jan;64(1):160-70. doi: 10.1016/j.jhep.2015.09.005. Epub 2015 Sep 21.

13.

ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis.

Fucho R, Martínez L, Baulies A, Torres S, Tarrats N, Fernandez A, Ribas V, Astudillo AM, Balsinde J, Garcia-Rovés P, Elena M, Bergheim I, Lotersztajn S, Trautwein C, Appelqvist H, Paton AW, Paton JC, Czaja MJ, Kaplowitz N, Fernandez-Checa JC, García-Ruiz C.

J Hepatol. 2014 Nov;61(5):1126-34. doi: 10.1016/j.jhep.2014.06.009. Epub 2014 Jun 16.

14.

CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis.

Rahman SM, Schroeder-Gloeckler JM, Janssen RC, Jiang H, Qadri I, Maclean KN, Friedman JE.

Hepatology. 2007 May;45(5):1108-17.

PMID:
17464987
15.

Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats.

Yang ZR, Wang HF, Zuo TC, Guan LL, Dai N.

BMC Pharmacol Toxicol. 2016 Apr 14;17:16. doi: 10.1186/s40360-016-0059-8.

16.

Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation.

Dattaroy D, Seth RK, Das S, Alhasson F, Chandrashekaran V, Michelotti G, Fan D, Nagarkatti M, Nagarkatti P, Diehl AM, Chatterjee S.

Am J Physiol Gastrointest Liver Physiol. 2016 Apr 1;310(7):G510-25. doi: 10.1152/ajpgi.00259.2015. Epub 2015 Dec 30.

17.

P2X7 receptor-NADPH oxidase axis mediates protein radical formation and Kupffer cell activation in carbon tetrachloride-mediated steatohepatitis in obese mice.

Chatterjee S, Rana R, Corbett J, Kadiiska MB, Goldstein J, Mason RP.

Free Radic Biol Med. 2012 May 1;52(9):1666-79. doi: 10.1016/j.freeradbiomed.2012.02.010. Epub 2012 Feb 15.

19.

CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis.

Zhang X, Shen J, Man K, Chu ES, Yau TO, Sung JC, Go MY, Deng J, Lu L, Wong VW, Sung JJ, Farrell G, Yu J.

J Hepatol. 2014 Dec;61(6):1365-75. doi: 10.1016/j.jhep.2014.07.006. Epub 2014 Jul 15.

20.

Resveratrol ameliorates hepatic steatosis and inflammation in methionine/choline-deficient diet-induced steatohepatitis through regulating autophagy.

Ji G, Wang Y, Deng Y, Li X, Jiang Z.

Lipids Health Dis. 2015 Oct 24;14:134. doi: 10.1186/s12944-015-0139-6.

Supplemental Content

Support Center